Structure Database (LMSD)
LMSD: Structure-based search results
LM_ID | Common Name | Systematic Name | Formula | Mass | Main Class | Sub Class |
---|---|---|---|---|---|---|
LMFA04010005 | 10-F4-NeuroP | (4Z,7Z,11E)-12-(3,5-dihydroxy-2-((Z)- pent-2-en-1-yl)cyclopentyl)-10- hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010043 | ent-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1R,2S,3S,5R)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010044 | ent-13-epi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010045 | ent-13-epi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010046 | ent-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010047 | 10-epi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010048 | 10,13-diepi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010049 | 10,13-diepi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010050 | 10-epi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010051 | ent-10-epi-4-Ft-NeuroP | (S,4Z,7Z,11E)-12-((1R,2S,3S,5R)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010052 | ent-10,13-diepi-4-Fc-NeuroP | (S,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010053 | ent-10,13-diepi-4-Ft-NeuroP | (S,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010054 | ent-10-epi-4-Fc-NeuroP | (S,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010055 | 10-F4c-NeuroP | (S,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010056 | 13-epi-10-F4t-NeuroP | (S,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010057 | 13-epi-10-F4c-NeuroP | (S,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
LMFA04010058 | 10-F4t-NeuroP | (S,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5- dihydroxy-2-((Z)-pent-2-en-1-yl) cyclopentyl)-10-hydroxydodeca-4,7,11- trienoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |